BROWSE·page 237 of 1397

Browse EX-10 agreements

16,757 total material contract exhibits.


EX-10.1

COLONY BANKCORP INC

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of this 13th day of September, 2026 (the “Effective Date”), is by and between Colony Bank (“Employer”), a Georgia Bank and wholly-owned subsidiary of Colony Bankcorp, Inc. (the “Holding Company”) and R. Dallis Copeland (“Employee”), a resident of the State of Georgia (collectively, the “Parties”).

WHEREAS, Employee is currently engaged as the President of both the Holding Company and Employer;

WHEREAS, the Holding Company, Employer and Employee desire to enter an employment agreement to memorialize the terms of Employee’s employment; and

NOW, THEREFORE, in consideration of the mutual covenants herein contained, Employer and Employee hereby agree as follows:

1. Employment.

(a)Agreement to Employ. Upon the terms and subject to the conditions of this Agreement, Employer hereby agrees to employ Employee and Employee hereby agrees to be employed with Employer as of the Effective Date.

…

EX-10.1·8-K·CIK 711669·ACC 0001104659-26-108432·Filed Sep 17, 2026, 08:30 ET

FORM OF COMPANY SUPPORT AGREEMENT

This Support Agreement (this “Agreement”) is made and entered into as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), Aethlon Medical, Inc., a Nevada corporation (“Parent”), and the undersigned stockholder of the Company (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

RECITALS

…

EX-10.2·8-K·CIK 882291·ACC 0001683168-26-007206·Filed Sep 17, 2026, 08:03 ET

FORM OF CVR AGREEMENT

AETHLON MEDICAL INC

FORM OF CONTINGENT VALUE RIGHTS AGREEMENT

This CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [__], 2026, is entered into by and among Aethlon Medical, Inc., a Nevada corporation (the “Company”), [__], a [__], as the “Rights Agent” (as defined herein), and Nicolas Gikakis, an individual, solely in his capacity as the initial representative, agent and attorney in fact of the Holders (the “Representative”).

RECITALS

…

EX-10.5·8-K·CIK 882291·ACC 0001683168-26-007206·Filed Sep 17, 2026, 08:03 ET


SECURITIES PURCHASE AGREEMENT

This SEC****URITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the “Securities Act”);

…

EX-10.4·8-K·CIK 882291·ACC 0001683168-26-007206·Filed Sep 17, 2026, 08:03 ET

FORM OF PARENT SUPPORT AGREEMENT

This Support Agreement (this “Agreement”) is made and entered into as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), Aethlon Medical, Inc., a Nevada corporation (“Parent”), and the undersigned stockholder of Parent (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

RECITALS

…

EX-10.1·8-K·CIK 882291·ACC 0001683168-26-007206·Filed Sep 17, 2026, 08:03 ET

FORM OF LOCK-UP AGREEMENT

AETHLON MEDICAL INC

** **


FORM OF LOCK-UP AGREEMENT

September 17, 2026

Aethlon Medical, Inc.

[__]

[__]

Attention: [__]

Email: [__]

Ladies and Gentlemen:

The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Aethlon Medical, Inc., a Nevada corporation (“Parent”), has entered into an Agreement and Plan of Merger and Reorganization, dated as of September 17, 2026 (as the same may be amended from time to time, the “Merger Agreement”) with Nighthawk Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of Parent, Nighthawk Second Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent, and North Immunology Inc., a Delaware corporation (the “Company”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement.

| | |

EX-10.3·8-K·CIK 882291·ACC 0001683168-26-007206·Filed Sep 17, 2026, 08:03 ET

**Ethena OpCo Ltd. **(the Company)

Craigmuir Chambers

Road Town, Tortola VG1110

British Virgin Islands

September 14, 2026

** **

To: StablecoinX Inc.
StablecoinX Assets Inc.
6160 Warren Pkwy, Suite 100
Frisco, TX 75034

** **

WAIVER LETTER

Dear Sirs,

This letter is addressed to StablecoinX Inc. (Pubco) and StablecoinX Assets Inc. (Opco, and together with Pubco and each of their respective subsidiaries, StablecoinX or You). Ethena Foundation (the Foundation) is a party to this letter for all purposes.

…

EX-10.1·8-K·CIK 2080215·ACC 0001213900-26-100751·Filed Sep 17, 2026, 08:00 ET

EX-10.1

CXJ GROUP CO., Ltd

Contract No. : Stock.2026.001

Subscription Agreement

** **

This Subscription Agreement (this “Agreement”) is made and entered into as of *September 8, 2026 *by and between CXJ Group Co., Limited, a Nevada corporation (the “Company”) and the undersigned (the “Purchaser”). The Purchaser, together with the Company shall be referred to as the “Parties”.

** **

WHEREAS, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company 124,000 of common stock, par value $0.001 per share of the Company (“Common Stock”) pursuant to an exemption from registration under Section 4(a)(2), Regulation D, and/or Regulation S under the Securities Act of 1933, as amended (the “1933 Act”) or other applicable exemptions on the terms and conditions set forth in this Agreement.

NOW, THEREFORE, in consideration of the mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:

…

EX-10.1·8-K·CIK 1823635·ACC 0001493152-26-043035·Filed Sep 17, 2026, 07:12 ET

EX-10.1

ACCENDRA HEALTH INC/VA/

EX-10.1·8-K·CIK 75252·ACC 0001104659-26-108405·Filed Sep 17, 2026, 06:35 ET

EXHIBIT 10.1

Cenntro Inc.


Exhibit 10.1

FIRST AMENDMENT

TO

SECURITIES PURCHASE AGREEMENT

This First Amendment to Securities Purchase Agreement (this “Amendment”) is made and entered into as of September 14, 2026 by and among Cenntro Inc., a Nevada corporation (the “Company”), and each of the purchasers (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”, and together with the Company, the “Parties”) identified on the signature pages to that certain Securities Purchase Agreement, dated as of August 25, 2026 (the “Purchase Agreement”). Capitalized terms used herein but not otherwise defined herein shall have the respective meanings assigned to such terms in the Purchase Agreement.

RECITALS:

A.WHEREAS, the Company and the Purchasers entered into the Purchase Agreement, which sets forth the Parties’ rights and obligations with respect to the transactions contemplated thereby;

…

EX-10.1·8-K·CIK 1707919·ACC 0001140361-26-036815·Filed Sep 16, 2026, 21:47 ET

FORM OF LOCK UP AGREEMENT

Lannister Mining Corp.

** **

LOCK-UP AGREEMENT

[____], 2026

Joseph Gunnar & Co., LLC

Research Capital Corporation

acting as Representatives of the

Several underwriters:

…

EX-10.17·F-1/A·CIK 1851535·ACC 0001213900-26-100639·Filed Sep 16, 2026, 19:01 ET